Kinetics of Intraperitoneally Infused Insulin In Rats: Functional Implications for the Bioartificial Pancreas
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Intraperitoneal transplantation of encapsulated islets can restore normoglycemia in diabetic recipients but not normal glucose tolerance nor normal insulin responses to a physiological stimulus. This study investigates whether the intraperitoneal implantation site as such contributes to the interference with optimal transport kinetics between the islets and the bloodstream. Insulin was infused into the peritoneal cavity of conscious and freely moving rats in doses of 20, 40, and 80 pmol · I−1 · min−1 during 15 min, to mimic the gradual release of insulin from an encapsulated, i.e., a nonvascularized, islet graft. With 20 pmol · I−1 · min−1, we observed virtually no rise of insulin levels, and it took 30 min until glucose levels had dropped significantly. With 40 and 80 pmol · I−1 · min−1 insulin infusions, there was a dose-dependent rise of insulin and decrease of glucose levels. When compared with intraportal infusions with the same insulin dosages, however, they were strongly delayed and reduced as well as prolonged. Similar results were obtained when inulin instead of insulin was intraperitoneally infused, which indicates that the transport of insulin from the peritoneal cavity to the bloodstream is mainly by passive diffusion. With a view on the clinical efficacy of the bioartificial pancreas, our findings indicate that we should focus on finding or creating a transplantation site that, more than the unmodified peritoneal cavity, permits close contact between the bloodstream and the encapsulated islet tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schwartz, N. S., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112884 · Cited by 394 · cited 1×
“It is unlikely that endogenous insulin has contributed to the patterns of uptake of the infused insulin since insulin administration is associated with a decrease of the blood glucose levels, which suppresses the endogenous production of insulin (24,25).”
BackgroundGlucose counterregulation: prevention and correction of hypoglycemia in humans
Cryer, P. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e149 · Cited by 198 · cited 2×
“This suggests inadequate counterregulation by glycogenolysis and suppression of glucose utilization (24,40).”
Background
Cited by
Alginate-based microcapsules for immunoisolation of pancreatic islets
de Vos, P., Faas, M. M., Strand, B., & Calafiore, R. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.07.010 · Cited by 511
Self-citationScharp, D. W., & Marchetti, P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.018 · Cited by 314
Polymers in cell encapsulation from an enveloped cell perspective
de Vos, P., Lazarjani, H. A., Poncelet, D., & Faas, M. M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.005 · Cited by 298
Vos, P. D., Haan, B. J. D., Wolters, G. H. J., Strubbe, J. H., & Schilfgaarde, R. V. (1997) · Diabetologia · doi:10.1007/s001250050673 · Cited by 279
Self-citationOptimal implantation site for pancreatic islet transplantation
Merani, S., Toso, C., Emamaullee, J., & Shapiro, A. M. J. (2008) · British Journal of Surgery · doi:10.1002/bjs.6391 · Cited by 257
Metadata
- Authors
- De Vos, P., Vegter, D., De Haan, B. J., Strubbe, J. H., Bruggink, J. E., & Van Schilfgaarde, R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1996-08-01
- Volume
- 45
- Issue
- 8
- Pages
- 1102-1107
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2097727959
- Cited by
- 61
- References
- 2
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.